tailieunhanh - Low back pain - Early management of persistent non-specific low back pain

Presentation is critical in making the information useful, and is often neglected. Reports should be clear, understandable, and meaningful. Even if all other steps in the outcome measurement process have gone well, poorly reported information will discourage use or provide misleading information. Outcome information can be reported in a variety of ways, as shown in exhibits 11, 12, and 13. Exhibit 11 (see page 19) presents data on one outcome indicator for a given reporting period broken out by individual service unit and race/ethnicity. Any two characteristics can be readily “cross-tabulated” and reported in such a format | NHS National Institute for Health and Clinical Excellence Issue date May 2009 Low back pain Early management of persistent non-specific low back pain NICE clinical guideline 88 Developed by the National Collaborating Centre for Primary Care NICE clinical guideline 88 Low back pain Ordering information You can download the following documents from CG88 The NICE guideline this document - all the recommendations. A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - a summary for patients and carers. The full guideline - all the recommendations details of how they were developed and reviews of the evidence they were based on. For printed copies of the quick reference guide or Understanding NICE guidance phone NICE publications on 0845 003 7783 or email publications@ and quote N1865 quick reference guide N1866 Understanding NICE guidance . NICE clinical guidelines are recommendations about the treatment and care of people with specific diseases and conditions in the NHS in England and Wales. This guidance represents the view of NICE which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer and informed by the summary of product characteristics of any drugs they are considering. Implementation of this guidance is the responsibility of local commissioners and or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance in their local context in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this .

• Y khoa - Dược
• Sub Saharan
• Tuberculosis continues
• mostly affected
• opportunistic infection
• Sub Saharan
• Antiretroviral adherence
• BMC Pediatrics
• Rheumatic heart disease
• Sub Saharan Africa
• Rheumatic valvular disease
• Echocardiographic examinations
• BMC Cancer
• Human papilloma virus
• Human papilloma virus related cancer
• HPV related conditions
• SubSaharan Africa
• Thematic analysis
• Public health
• Health Insurance
• Propensity score matching
• Difference in differences
• Adherence measures
• Antiretroviral prophylaxis
• Maternal verbal report
• Pharmacy returns
• Antiretroviral therapy
• Caregiver reported adherence
• HIV infected children
• Regimen characteristics
• BMC Women's Health
• Long acting injectable
• ART adherence
• Phase 3 trials
• antiretroviral treatment
• HIV associated